Why is Kwality Pharma falling/rising?

As of 11-Sep, Kwality Pharmaceuticals Ltd is currently priced at 969.30, reflecting a decline of 7.6 points or 0.78%. Today's performance indicates that the stock has underperformed its sector by 1.25%, with an intraday low of Rs 940, marking a decrease of 3.78%. Despite this drop, the stock has shown a positive trend over the past week with a return of 4.20%, although it has experienced a significant decline of 7.91% over the past month. The company has demonstrated strong financial health with a low Debt to EBITDA ratio of 1.03 times and has reported positive results for the last six consecutive quarters, including a 48.91% growth in PAT and a 32.02% increase in net sales. The stock is currently trading at a discount compared to its peers, which may provide a fair valuation despite its recent price drop.
In the broader market context, while the stock has generated a return of 16.16% over the past year, the benchmark index, BSE500, has seen negative returns of -2.29% during the same period, indicating that Kwality Pharmaceuticals has outperformed the market overall. However, the recent decline in its stock price suggests that short-term investor sentiment may be influenced by the stock's underperformance today and the recent volatility reflected in its moving averages. The rising investor participation, with a 26.09% increase in delivery volume, may indicate a potential for recovery, but the current price movement suggests caution among investors in the short term.